Truist Financial
NVRO

Truist Financial’s NEVRO CORP. NVRO Stock Holding History

Truist Financial’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,079
Closed -$270K – 2762
2024
Q2 		$270K Sell
32,079
-1,379
-4% -$14.7K ﹤0.01% 2341
2024
Q1 		$483K Sell
33,458
-5,038
-13% -$83.3K ﹤0.01% 1981
2023
Q4 		$828K Buy
38,496
+8,247
+27% +$147K ﹤0.01% 1697
2023
Q3 		$581K Sell
30,249
-731
-2% -$15.6K ﹤0.01% 1842
2023
Q2 		$788K Sell
30,980
-1,338
-4% -$38.6K ﹤0.01% 1702
2023
Q1 		$1.17M Buy
32,318
+218
+0.7% +$7.66K ﹤0.01% 1479
2022
Q4 		$1.27M Buy
32,100
+8,994
+39% +$374K ﹤0.01% 1439
2022
Q3 		$1.08M Sell
23,106
-8,873
-28% -$412K ﹤0.01% 1461
2022
Q2 		$1.4M Buy
31,979
+9,032
+39% +$497K ﹤0.01% 1386
2022
Q1 		$1.66M Sell
22,947
-5,368
-19% -$387K ﹤0.01% 1375
2021
Q4 		$2.3M Sell
28,315
-8,027
-22% -$804K ﹤0.01% 1233
2021
Q3 		$4.23M Sell
36,342
-813
-2% -$106K 0.01% 947
2021
Q2 		$6.16M Buy
37,155
+5,099
+16% +$796K 0.01% 800
2021
Q1 		$4.47M Buy
32,056
+8,148
+34% +$1.33M 0.01% 880
2020
Q4 		$4.14M Buy
23,908
+4,127
+21% +$668K 0.01% 876
2020
Q3 		$2.76M Buy
19,781
+3,562
+22% +$476K 0.01% 946
2020
Q2 		$1.94M Buy
16,219
+2,485
+18% +$295K ﹤0.01% 1043
2020
Q1 		$1.37M Sell
13,734
-844
-6% -$102K ﹤0.01% 1131
2019
Q4 		$1.71M Buy
+14,578
New +$1.44M ﹤0.01% 1199

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Truist Financial's NVRO Position: Q3 2024 in Review

Truist Financial sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 32,079 shares — an estimated $270K sold.

Truist Financial first reported a position in NVRO in Q4 2019 and held it in 19 quarters. The position peaked at $6.16M in Q2 2021. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Truist Financial reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Truist Financial sold 32,079 NEVRO CORP. shares in Q3 2024, an estimated $270K.
  • Truist Financial first reported a position in NEVRO CORP. in Q4 2019 and held it in 19 quarters.
  • Truist Financial's NEVRO CORP. position peaked at $6.16M in Q2 2021.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on Truist Financial's 13F filing for Q3 2024, filed 13 Nov 2024.